HIV-1 Tat induces biochemical changes in the serum of mice

Virology

Volumn 422, Issue 2, 2012, Pages 288-296

  Liao, Wenting ^a   Tan, Guangguo ^a   Zhu, Zhenyu ^a   Chen, Qiuli ^a   Lou, Ziyang ^a   Dong, Xin ^a   Zhang, Wei ^a   Pan, Wei ^a   Chai, Yifeng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

GC MS; HIV 1 Tat protein; Metabolomics; Multivariate data analysis

Indexed keywords

ALANINE; ALPHA TOCOPHEROL; ARACHIDONIC ACID; CITRIC ACID; GLUTAMINE; LACTIC ACID; LINOLEIC ACID; MALIC ACID; PALMITIC ACID; PHENYLALANINE; PROLINE; STEARIC ACID; SUCCINIC ACID; TRANSACTIVATOR PROTEIN; TRYPTOPHAN; TYROSINE; URIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; MOUSE; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SERUM; VIRUS VIRULENCE;

ANIMALS; DISCRIMINANT ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MICE; MICE, INBRED ICR; MUTATION; PRINCIPAL COMPONENT ANALYSIS; RECOMBINANT PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION; TRYPTOPHAN;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 84855191868     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.005     Document Type: Article

References (61)

1. Agwale S.M., Shata M.T., Reitz M.S., Kalyanaraman V.S., Gallo R.C., Popovic M., Hone D.M. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(15):10037-10041.
2. Avraham H.K., Jiang S., Lee T.H., Prakash O., Avraham S. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J. Immunol. 2004, 173(10):6228-6233.
3. Banerjee A., Zhang X.S., Manda K.R., Banks W.A., Ercal N. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic. Biol. Med. 2010, 48(10):1388-1398.
4. Barillari G., Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin. Microbiol. Rev. 2002, 15(2):310-326.
5. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 2003, 3(2):169-176.
6. Bruce S.J., Tavazzi I., Parisod V., Rezzi S., Kochhar S., Guy P.A. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal. Chem. 2009, 81(9):3285-3296.
7. Campbell G.R., Loret E.P. What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?. Retrovirology 2009, 6:50.
8. Carlucci F., Tabucchi A., Perrett D., Pizzichini M., Rosi F., Pagani R., Marinello E. Purine metabolism in HIV-1 virus-infected T lymphocyte population. Biomed. Pharmacother. 1996, 50(10):505-509.
9. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997, 11(12):1421-1431.
10. Chi X., Amet T., Byrd D., Chang K.-H., Shah K., Hu N., Grantham A., Hu S., Duan J., Tao F., Nicol G., Yu Q. Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain. PLoS One 2011, 6(9):e24412.
11. Cohen S.S., Li C., Ding L.N., Cao Y.Z., Pardee A.B., Shevach E.M., Cohen D.I. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(19):10842-10847.
12. Corallini A., Altavilla G., Pozzi L., Bignozzi F., Negrini M., Rimessi P., Gualandi F., Barbantibrodano G. Systemic expression of Hiv-1 Tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res. 1993, 53(22):5569-5575.
13. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345(6270):84-86.
14. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 1993, 67(1):277-287.
15. Gallo R.C. Tat as one key to HIV-induced immune pathogenesis and Pat toroid as an important component of a vaccine. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(15):8324-8326.
16. Gavriil E.S., Cooney R., Weeks B.S. Tat mediates apoptosis in vivo in the rat central nervous system. Biochem. Biophys. Res. Commun. 2000, 267(1):252-256.
17. Giunta B., Hou H., Zhu Y., Rrapo E., Tian J., Takashi M., Commins D., Singer E., He J., Fernandez F., Tan J. HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int. J. Clin. Exp. Pathol. 2009, 2(5):433-443.
18. Holden C.P., Haughey N.J., Nath A., Geiger J.D. Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes. Neuroscience 1999, 91(4):1369-1378.
19. Huang L.M., Joshi A., Willey R., Orenstein J., Jeang K.T. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 1994, 13(12):2886-2896.
20. Huang X., Shao L., Gong Y., Mao Y., Liu C., Qu H., Cheng Y. A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 870(2):178-185.
21. Jiang M.-C., Lin J.-K., Chen S.S.L. Inhibition of HIV-1 Tat-mediated Transactivation by quinacrine and chloroquine. Biochem. Biophys. Res. Commun. 1996, 226(1):1-7.
22. Jiang N., Yan X., Zhou W., Zhang Q., Chen H., Zhang Y., Zhang X. NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. J. Proteome. Res. 2008, 7(9):3678-3686.
23. Jonsson P., Gullberg J., Nordstrom A., Kusano M., Kowalczyk M., Sjostrom M., Moritz T. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal. Chem. 2004, 76(6):1738-1745.
24. Jonsson P., Johansson A.I., Gullberg J., Trygg J., A, J., Grung B., Marklund S., Sjostrom M., Antti H., Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal. Chem. 2005, 77(17):5635-5642.
25. Khan W.A., Blobe G.C., Hannun Y.A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell. Signal. 1995, 7(3):171-184.
26. Kim B.O., Liu Y., Ruan Y., Xu Z.C., Schantz L., He J.J. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am. J. Pathol. 2003, 162(5):1693-1707.
27. Larsson M., Hagberg L., Norkrans G., Forsman A. Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J. Neurosci. Res. 1989, 23(4):441-446.
28. Li W., Galey D., Mattson M.P., Nath A. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox. Res. 2005, 8(1-2):119-134.
29. Mahadevan S., Shah S.L., Marrie T.J., Slupsky C.M. Analysis of metabolomic data using support vector machines. Anal. Chem. 2008, 80(19):7562-7570.
30. Marchio S., Alfano M., Primo L., Gramaglia D., Butini L., Gennero L., De Vivo E., Arap W., Giacca M., Pasqualini R., Bussolino F. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. Blood 2005, 105(7):2802-2811.
31. Mischiati C., Pironi F., Milani D., Giacca M., Mirandola P., Capitani S., Zauli G. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS 1999, 13(13):1637-1645.
32. Murray M.F. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect. Dis. 2003, 3(10):644-652.
33. Pasikanti K.K., Esuvaranathan K., Ho P.C., Mahendran R., Kamaraj R., Wu Q.H., Chiong E., Chan E.C.Y. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J. Proteome Res. 2010, 9(6):2988-2995.
34. Pendyala G., Trauger S.A., Siuzdak G., Fox H.S. Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J. Proteome Res. 2010, 9(1):352-358.
35. Perez A., Probert A.W., Wang K.K., Sharmeen L. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J. Neurovirol. 2001, 7(1):1-10.
36. Perry S.W., Barbieri J., Tong N., Polesskaya O., Pudasaini S., Stout A., Lu R., Kiebala M., Maggirwar S.B., Gelbard H.A. Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J. Neurosci. 2010, 30(42):14153-14164.
37. Petsch D., Anspach F.B. Endotoxin removal from protein solutions. J. Biotechnol. 2000, 76(2-3):97-119.
38. Pocernich C.B., Sultana R., Mohmmad-Abdul H., Nath A., Butterfield D.A. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res. Brain Res. Rev. 2005, 50(1):14-26.
39. Prakash O., Teng S., Ali M., Zhu X.Z., Coleman R., Dabdoub R.A., Chambers R., Aw T.Y., Flores S.C., Joshi B.H. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Arch. Biochem. Biophys. 1997, 343(2):173-180.
40. Prasada Rao P.V., Gardner D.E. Effects of cadmium inhalation on mitochondrial enzymes in rat tissues. J. Toxicol. Environ. Health 1986, 17(2-3):191-199.
41. Ramonet D., Rodriguez M.J., Fredriksson K., Bernal F., Mahy N. In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death. Hippocampus 2004, 14(5):586-594.
42. Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A., Lowry C.A. Tryptophan metabolism in the central nervous system: medical implications. Expert. Rev. Mol. Med. 2006, 8(20):1-27.
43. Rusnati M., Presta M. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis 2002, 5(3):141-151.
44. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 1991, 65(2):961-967.
45. Sabatine M.S., Liu E., Morrow D.A., Heller E., McCarroll R., Wiegand R., Berriz G.F., Roth F.P., Gerszten R.E. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005, 112(25):3868-3875.
46. Samikkannu T., Rao K.V., Gandhi N., Saxena S.K., Nair M.P. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: implications for neuroAIDS. J. Neurovirol. 2010, 16(4):255-263.
47. Schousboe A. Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem. Res. 2003, 28(2):347-352.
48. Sekhar R.V., Jahoor F., White A.C., Pownall H.J., Visnegarwala F., Rodriguez-Barradas M.C., Sharma M., Reeds P.J., Balasubramanyam A. Metabolic basis of HIV-lipodystrophy syndrome. Am. J. Physiol. Endocrinol. Metab. 2002, 283(2):E332-E337.
49. Shrivastav S., Kino T., Cunningham T., Ichijo T., Schubert U., Heinklein P., Chrousos G.P., Kopp J.B. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor gamma and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy. Mol. Endocrinol. 2008, 22(2):234-247.
50. Siddappa N.B., Venkatramanan M., Venkatesh P., Janki M.V., Jayasuryan N., Desai A., Ravi V., Ranga U. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 2006, 3.
51. Silvers J.M., Aksenova M.V., Aksenov M.Y., Mactutus C.F., Booze R.M. Neurotoxicity of HIV-1 tat protein: involvement of D1 dopamine receptor. Neurotoxicology 2007, 28(6):1184-1190.
52. Slama L., Le Camus C., Serfaty L., Pialoux G., Capeau J., Gharakhanian S. Metabolic disorders and chronic viral disease: the case of HIV and HCV. Diabetes Metab. 2009, 35(1):1-11.
53. Smith S.M., Pentlicky S., Klase Z., Singh M., Neuveut C., Lu C.Y., Reitz M.S., Yarchoan R., Marx P.A., Jeang K.T. An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J. Biol. Chem. 2003, 278(45):44816-44825.
54. Storey J.D. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B 2002, 64:479-498.
55. Subramanyam M., Gutheil W.G., Bachovchin W.W., Huber B.T. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 1993, 150(6):2544-2553.
56. Tabucchi A., Carlucci F., Ramazzotti E., Re M.C., Marinello F., Rubino M., Pagani R. Analysis of purine nucleotides in lymphocytes from healthy subjects and AIDS patients. Biomed. Pharmacother. 1992, 46(1):25-29.
57. Tabucchi A., Carlucci F., Re M.C., Furlini G., Consolmagno E., Leoncini R., Pizzichini M., Marinello E., Rubino M., Pagani R. The behavior of free purine nucleotides in lymphocytes infected with HIV-1 virus. Biochim. Biophys. Acta 1993, 1182(3):317-322.
58. Viscidi R.P., Mayur K., Lederman H.M., Frankel A.D. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989, 246(4937):1606-1608.
59. Want E.J., Nordstrom A., Morita H., Siuzdak G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome Res. 2007, 6:459-468.
60. Werner E.R., Fuchs D., Hausen A., Jaeger H., Reibnegger G., Werner-Felmayer G., Dierich M.P., Wachter H. Tryptophan degradation in patients infected by human immunodeficiency virus. Biol. Chem. Hoppe Seyler 1988, 369(5):337-340.
61. Wikoff W.R., Pendyala G., Siuzdak G., Fox H.S. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J. Clin. Invest. 2008, 118(7):2661-2669.